E Fund Management (HK)’s Vertex Pharmaceuticals VRTX Stock Holding History
Bought
Maintained
Sold
Other funds holding VRTX
E Fund Management (HK)'s VRTX Position: Q3 2026 in Review
E Fund Management (HK) increased its Vertex Pharmaceuticals (VRTX) stake by 52% in Q3 2026, buying an estimated $393K and bringing the position to 2,250 shares worth $1.18M. The position accounts for 0.27% of the portfolio, ranked #59.
E Fund Management (HK) first reported a position in VRTX in Q3 2022 and has held it in 11 quarters since. The position peaked at $1.88M in Q3 2022. 1,556 funds tracked by Wall St. Rank hold VRTX as of Q3 2026.
- E Fund Management (HK) held 2,250 shares of Vertex Pharmaceuticals worth $1.18M as of Q3 2026.
- E Fund Management (HK) bought 767 Vertex Pharmaceuticals shares in Q3 2026, an estimated $393K.
- Vertex Pharmaceuticals made up 0.27% of E Fund Management (HK)'s portfolio in Q3 2026, its #59 holding.
- E Fund Management (HK) first reported a position in Vertex Pharmaceuticals in Q3 2022 and has held it in 11 quarters since.
- E Fund Management (HK)'s Vertex Pharmaceuticals position peaked at $1.88M in Q3 2022.
- 1,556 funds tracked by Wall St. Rank held Vertex Pharmaceuticals as of Q3 2026.
Based on E Fund Management (HK)'s 13F filing for Q3 2026, filed 12 Nov 2026.